1885
CONCLUSIONS : Etoricoxib 90 mg demonstrated a significantly lower risk for discontinuing treatment due to GI AEs compared with diclofenac 150 mg .
 Chemical: Etoricoxib; Disease: GI AEs; Chemical: diclofenac
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Disease, Chemical 
Text: {0} 
Answer:
 Chemical: Etoricoxib; Disease: GI AEs; Chemical: diclofenac